ribavirin has been researched along with Depression in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 34 (40.00) | 29.6817 |
| 2010's | 48 (56.47) | 24.3611 |
| 2020's | 3 (3.53) | 2.80 |
| Authors | Studies |
|---|---|
| Bebek-Ivankovic, H; Bevanda, M; Grgic, S; Nikolic, J; Soldo-Coric, L; Susak, B | 1 |
| Bugajska, J; Inglot, M; Janocha-Litwin, J; Malyszczak, K; Marciniak, D; Pawlak, D; Pawlowski, T; Zalewska, M | 1 |
| Baumert, TF; Berg, T; Brants, L; Buggisch, P; Discher, T; Friebe, A; Fromm, G; Kemper, J; Lieb, K; Link, R; Ockenga, J; Reimer, J; Rentrop, M; Sarkar, R; Sarkar, S; Schaefer, M; Schläpfer, T; Spengler, U; Weidenbach, H; Zeuzem, S | 1 |
| Baeg, JY; Cho, J; Chung, JW; Jang, ES; Jeong, SH; Jung, EU; Kim, IH; Kim, JW; Kim, YS; Seo, SY | 1 |
| Barbosa, MED; Carrilho, FJ; de Campos Mazo, DF; de Oliveira, CPMS; Farias, AQ; Pessoa, MG; Zaninotto, AL | 1 |
| Bräu, N; Dieterich, DT; Gorman, JM; Marcus, SM; Prieto, S; Stivala, A; Weiss, JJ | 1 |
| Gruenhage, F; Hahn, D; Kaiser, R; Lammert, F; Meyer, MR; Stokes, CS | 1 |
| Gross, R; Guyatt, G; Lev-Ran, S; Saad, A; Yekutieli, D | 1 |
| Frydecka, D; Hadryś, T; Inglot, M; Małyszczak, K; Pawłowski, T | 1 |
| Ahmed, GK; Darwish, AM; Hassaan, SH; Hassany, SM; Khalifa, H; Moustafa, EF; Ramadan, HKA | 1 |
| Bourlière, M; Bronowicki, JP; Chimienti, F; Cleophax, S; Doffoel, M; Lang, JP; Pujol, JF; Salvetat, N; Schwan, R; Van der Laan, S; Vire, B; Weissmann, D | 1 |
| Hopwood, M | 1 |
| Capuron, L; de la Torre, R; Giménez, D; Gratacòs, M; Langohr, K; Martín-Santos, R; Moreno-España, J; Navinés, R; Solà, R; Udina, M | 1 |
| Amano, K; Arinaga, T; Fujimoto, Y; Ide, T; Ishii, K; Kuhara, K; Kumashiro, R; Kuwahara, R; Miyajima, I; Morita, Y; Murashima, S; Ogata, K; Sakai, K; Sata, M; Shirachi, M; Uchimura, N | 1 |
| Anderson, RT; Baran, RW; Dietz, B; Erickson, P; Gooch, K; Revicki, DA | 1 |
| Bride, BE; Nackerud, LG; Sims, OT; Whalen, CC | 1 |
| Hou, XJ; Wang, J; Xu, JH; Yu, YY | 1 |
| Bonner, JE; Esserman, DA; Evon, DM; Golin, CE | 1 |
| Bayliss, MS; Crosby, RD; L'Italien, G; Mathias, S; Sapra, S | 1 |
| Baranyi, A; Kapfhammer, HP; Meinitzer, A; Putz-Bankuti, C; Rothenhäusler, HB; Stauber, R | 1 |
| Blunn, A; Chitturi, S; Farrell, G; Kaye, G; Rodrigo, K; Rodriguez-Morales, I; Shadbolt, B; Teoh, N; To, C; Wu, JY | 1 |
| Avasthi, A; Chawla, YK; Grover, S; Mahajan, S | 1 |
| Bezemer, G; de Knegt, RJ; Hansen, BE; Hotho, DM; Janssen, HL; Van Gool, AR; Veldt, BJ | 1 |
| Barakat, F; Cattie, JE; Cherner, M; Franklin, D; Grant, I; Hassanein, T; Heaton, RK; Letendre, SL; Perry, W; Umlauf, A; Woods, SP | 1 |
| Kawano, A; Miyagi, Y; Nomura, H; Tanimoto, H; Yamashita, N | 1 |
| Arbuckle, R; Beumont, M; Brohan, E; Fu, M; Gilles, L; Jessner, W; Panter, C; Scott, J | 1 |
| Ferenci, P; Ferenci-Förster, D; Hagmann, M; Kienbacher, C; Miehsler, W; Moser, G; Reichhold, D; Scherzer, TM; Staufer, K | 1 |
| Joshita, S; Tanaka, E | 1 |
| Eccles, J; Fialho, R; File, A; Haq, I; Keller, M; Pereira, M; Rolt, M; Tibble, J; Whale, R | 1 |
| Felger, JC; Haroon, E; Miller, AH; Raison, CL; Woolwine, BJ | 1 |
| Artigas, F; Egmond, E; Gimenez, D; Gómez-Gil, E; Grande, I; Gratacós, M; Kapczinski, F; Langohr, K; Martín-Santos, R; Navinés, R; Oriolo, G; Solà, R; Udina, M; Valdés, M; Vieta, E | 1 |
| Bertino, G; Caraci, F; Chisari, G; Drago, F; Greco, C; Malaguarnera, G; Malaguarnera, M; Motta, M; Nunnari, G; Vacante, M; Vecchio, M | 1 |
| Chang, JJ; Chen, CK; Chen, LW; Chen, SW; Chien, RN; Lee, TS; Liu, CJ; Wang, LJ; Yen, CL | 1 |
| Frydecka, D; Małyszczak, K; Pawlak, D; Pawłowski, T | 1 |
| Borisov, AS; Massung, B; Miller, AH; Raison, CL; Vogt, G; Woolwine, BJ | 1 |
| Hopwood, M; Treloar, C | 1 |
| Back-Madruga, C; Bieliauskas, LA; Fontana, RJ; Kronfol, Z; Lindsay, KL; Lok, AS; Padmanabhan, L; Stoddard, AM | 1 |
| Ferenci, P | 1 |
| Conti, CM; Dalessandro, M; Falasca, K; Mancino, P; Manzoli, L; Pizzigallo, E; Ucciferri, C; Vecchiet, J | 1 |
| Alvarez-Uria, G; Day, JN; Nasir, AJ; Russell, SK; Vilar, FJ | 1 |
| Poll, R | 1 |
| Belle, SH; Evon, DM; Fontana, RJ; Fried, MW; Ramcharran, D; Terrault, NA | 1 |
| Keicher, C; Kraus, MR; Rieger, P; Schäfer, A; Scheurlen, M; Seufert, J; Weissbrich, B | 1 |
| Dantzer, R; Kelley, KW; Lawson, MA; Miller, AH; Raison, CL; Saito, K; Spivey, JR; Vogt, G; Woolwine, BJ | 1 |
| Ackermann, G; Waizmann, M | 1 |
| Kenis, G; Koek, GH; Prickaerts, J; Robaeys, G; Steinbusch, HW; van Os, J; Wichers, M | 1 |
| Brown, GR; Cubillas, R; Grumbeck, C; Hale, T; Phillips, FH; Prebis, M | 1 |
| Abate, G; Bertino, G; Boemi, P; Calvagno, GS; Di Pino, A; Giancarlo, C; Ignaccolo, L; Judica, A; Maiorca, D; Mastrosimone, G; Mauceri, B; Misseri, M; Neri, S; Palermo, F; Petralia, A; Rizzotto, A; Vadalà, G | 1 |
| Bernardinello, E; Bertazzo, A; Cavalletto, L; Chemello, L; Comai, S; Costa, CV; Ragazzi, E | 1 |
| Alagbe, O; Felger, JC; Hu, F; Miller, AH; Pace, TW; Raison, CL; Woolwine, BJ | 1 |
| Carral Martínez, M; García-Toro, M; Gili Planas, M; Jimeno Beltrán, T; Pradas Guerrero, C; Roca Bennasar, M; Román Ruiz del Moral, Y; Vilella Martorell, A | 1 |
| de Oliveira, IR; Galvão-de Almeida, A; Guindalini, C; Koenen, KC; Lyra, AC; Miranda-Scippa, A; Paraná, R; Parise, CL; Quarantini, LC; Sampaio, AS | 1 |
| Carrieri, MP; Dabis, F; Fugon, L; Lacombe, K; Roux, P; Salmon-Céron, D; Sogni, P; Spire, B; Winnock, M | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Imai, N; Kawamura, Y; Kobayashi, M; Kumada, H; Matsumoto, N; Saito, S; Seko, Y; Sezaki, H; Suzuki, F; Suzuki, Y | 1 |
| Lou, M; Park, SH; Wackernah, RC | 1 |
| Alavi, M; Day, C; Dore, GJ; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Van Beek, I; Yeung, B | 1 |
| Cole, SW; Doho, GH; Felger, JC; Hu, F; Miller, AH; Pace, TW; Raison, CL; Woolwine, BJ | 1 |
| Andersen, JW; Butt, AA; Chung, RT; Hua, L; Kemmer, N; Sherman, KE | 1 |
| Durández Lazaro, R; Fábregas Puigtió, S; Planas Vilà, R; Vega Palomares, R | 1 |
| Folwaczny, C; Grunze, H; Heldwein, W; Koenig, A; Loeschke, K; Lorenz, R; Martin, G; Schaefer, M; Schindlbeck, N; Schmidt, F; Soyka, M | 1 |
| Hadziyannis, S; Koskinas, J; Manesis, E; Merkouraki, P | 1 |
| Ball, L; Berggren, R; Dieterich, DT; Felizarta, F; Goodman, R; Khalili, M; Slim, J; Smith, C; Sulkowski, MS | 1 |
| Bagheri, H; Barange, K; Fouladi, A; Lapeyre-Mestre, M; Montastruc, JL; Payen, JL; Vinel, JP | 1 |
| Biglia, A; Blanch, J; Blanco, JL; de Pablo, J; García, F; Gatell, JM; Laguno, M; Larrousse, M; León, A; Lonca, M; Mallolas, J; Martinez, E; Miró, JM; Murillas, J | 1 |
| Al-Taie, O; Kraus, MR; Schäfer, A; Scheurlen, M | 1 |
| Barry, K; Cleare, AJ; Hotopf, M; Landau, S; Maddock, C; Maulayah, P; Norris, S; Pariante, CM | 1 |
| Apale, P; Avolio, A; Bellia, V; Bordoni, T; Parravicini, P; Pioltelli, P; Pozzi, M; Redaelli, A; Roffi, L; Santamaria, G; Scalori, A | 1 |
| Czarnecki, M; Gładysz, A; Inglot, M; Jańczak, G; Małyszczak, K; Pawłowski, T; Rymer, W | 1 |
| Antinori, A; Carioti, J; Caroleo, B; Guadagnino, V; Trotta, MP | 1 |
| Gholam, PM; Rich, JD; Schwartzapfel, B; Taylor, LE | 1 |
| Crone, C; Dan, AA; Farmer, DW; Martin, LM; Ong, JP; Robbins, SC; Wise, T; Younossi, ZM | 1 |
| Chang, WW; Chen, CL; Cheng, JT; Fan, CW; Lin, YS; Lo, HY; Tsao, CW; Wu, SR | 1 |
| De Heusden, N; Fischer, K; Mauser-Bunschoten, EP; Posthouwer, D | 1 |
| Bardadin, K; Berak, H; Horban, A; Paprocka, H; Stańczak, JJ; Wasilewski, M | 1 |
| Kallman, J; Kincaid, J; Younossi, Z | 1 |
| Bonkovsky, H; Faris-Young, S; Huntley, B; Lyons, MF; Reddy, KR; Ryan, M; Santoro, J; Sjogren, MH; Sjogren, R; Smith, C | 1 |
| Fucci, JC; Gleason, OC; Philipsen, MA; Yates, WR | 1 |
| Kraus, MR; Schäfer, A; Scheurlen, M; Schöttker, K; Weissbrich, B | 1 |
| Berg, T; Friebe, A; Gutsche, J; Halangk, J; Heinz, A; Hinzpeter, A; Janssen, G; Kluschke, M; Mohmand, A; Pich, M; Sarkar, R; Schaefer, M; Schwaiger, M; Weich, V; Ziemer, M | 1 |
| Ardevol, M; Castellví, P; Díez-Quevedo, C; Galeras, JA; García, F; Martín-Santos, R; Masnou, H; Miquel, M; Navinés, R; Planas, R; Solà, R; Soler, A | 1 |
| Esposito, S; Hamzeh, FM; Rustgi, VK; Shiffman, ML | 1 |
| Capuron, L; Majer, M; Miller, AH; Pagnoni, G; Raison, CL; Welberg, LA | 1 |
| Annable, L; Benkelfat, C; Brouillette, MJ; Cooper, C; Klein, MB; Kraus, D; Sheehan, NL; Singer, J; Weston, F | 1 |
| Aitchison, KJ; Alexander, N; Binder, EB; Bull, SJ; Cassidy, E; Cleare, AJ; Cubells, JF; Hotopf, M; Huezo-Diaz, P; Maddock, C; Miller, AH; Miyazaki, C; Norris, S; Pariante, CM; Ranjith, G | 1 |
| Fontana, RJ | 1 |
6 review(s) available for ribavirin and Depression
| Article | Year |
|---|---|
Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?
Topics: Antidepressive Agents; Antiviral Agents; Citalopram; Depression; Double-Blind Method; Hepatitis C, Chronic; Humans; Interferon-alpha; Paroxetine; Polyethylene Glycols; Randomized Controlled Trials as Topic; Ribavirin; Treatment Outcome | 2013 |
Peginterferon and ribavirin in HCV: improvement of sustained viral response.
Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Medication Adherence; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome | 2008 |
The role of the community nurse in hepatitis C diagnosis and treatment.
Topics: Antiviral Agents; Community Health Nursing; Depression; Drug Monitoring; Fatigue; Hepatitis C; Humans; Infection Control; Interferon alpha-2; Interferon-alpha; Neutropenia; Nurse's Role; Nursing Assessment; Patient Education as Topic; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Social Support; United Kingdom | 2009 |
[Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Topics: Acute Disease; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Hyperbilirubinemia; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Spain; Thyroiditis; Viral Load; Viremia | 2002 |
The effects of HCV infection and management on health-related quality of life.
Topics: Antiviral Agents; Chronic Disease; Depression; Fatigue; Health Status; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2007 |
Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C.
Topics: Antiviral Agents; Anxiety; Chronic Disease; Cognition; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Sleep Initiation and Maintenance Disorders | 2000 |
24 trial(s) available for ribavirin and Depression
| Article | Year |
|---|---|
RNA editing blood biomarkers for predicting mood alterations in HCV patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Deaminase; Adult; Aged; Antiviral Agents; Biomarkers; Depression; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA Editing | 2019 |
Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Anxiety; Data Interpretation, Statistical; Depression; Drug Therapy, Combination; Female; Health Status Indicators; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Patient Outcome Assessment; Placebos; Psychometrics; Quality of Life; Reproducibility of Results; Ribavirin; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diary.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Factor Analysis, Statistical; Fatigue; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Minnesota; Musculoskeletal Pain; Psychiatric Status Rating Scales; Reproducibility of Results; Ribavirin; Self Report; Severity of Illness Index; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome; Virginia; Young Adult | 2014 |
Effects of escitalopram prophylaxis during antiviral treatment for chronic hepatitis C in patients with a history of intravenous drug use and depression.
Topics: Aged; Antiviral Agents; Citalopram; Comorbidity; Depression; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Placebos; Ribavirin; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2014 |
Weight loss during telaprevir-based triple therapy due to telaprevir-induced appetite loss.
Topics: Antiviral Agents; Appetite; Body Weight; Depression; Drug Therapy, Combination; Female; Genotype; Ghrelin; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Ribavirin; Treatment Outcome; Weight Loss | 2014 |
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 an
Topics: Adolescent; Adult; Aged; Anemia; Depression; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Fatigue; Female; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver; Male; Middle Aged; Placebos; Ribavirin; Simeprevir; Treatment Outcome; Viral Load; Young Adult | 2015 |
Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.
Topics: Adult; Antioxidants; Antiviral Agents; Anxiety; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Psychiatric Status Rating Scales; Ribavirin; Silybin; Silymarin; Treatment Outcome; Work Performance | 2016 |
Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Topics: Antiviral Agents; Anxiety; China; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2016 |
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.
Topics: Adrenocorticotropic Hormone; Adult; Antiviral Agents; Circadian Rhythm; Cytokines; Depression; Enzyme-Linked Immunosorbent Assay; Fatigue; Female; Hepatitis C; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Pituitary-Adrenal System; Ribavirin; Statistics as Topic; Statistics, Nonparametric | 2010 |
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
Topics: Antiviral Agents; Brain-Derived Neurotrophic Factor; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunologic Factors; Interferon-alpha; Male; Psychiatric Status Rating Scales; Ribavirin; Time Factors | 2011 |
Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-α-2b and ribavirin.
Topics: Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; Depression; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Self Report; Surveys and Questionnaires; Texas; Time Factors; Treatment Outcome; Veterans; Viral Load | 2010 |
A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
Topics: Antiviral Agents; Depression; Drug Monitoring; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Psychotherapy; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2010 |
Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.
Topics: Antiviral Agents; Depression; Drug Therapy, Combination; Fatigue; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunity, Innate; Interferon alpha-2; Interferon-alpha; Interleukin-6; Lymphocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polyethylene Glycols; Protein Processing, Post-Translational; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors | 2011 |
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Drug Users; Employment; Female; Hepatitis C; HIV Seropositivity; Humans; Interferon-alpha; Logistic Models; Male; Mental Health; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Participation; Substance Abuse, Intravenous; Surveys and Questionnaires; Viral Load; Young Adult | 2012 |
Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
Topics: 2',5'-Oligoadenylate Synthetase; Antiviral Agents; Computational Biology; Depression; Drug Therapy, Combination; Fatigue; Female; Gene Expression Profiling; Gene Expression Regulation; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocytes, Mononuclear; Longitudinal Studies; Male; Microarray Analysis; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; Severity of Illness Index | 2012 |
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.
Topics: Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Treatment Outcome | 2012 |
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.
Topics: Adult; Antiviral Agents; Depression; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2004 |
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
Topics: Adult; Antiviral Agents; Anxiety; Depression; Drug Carriers; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance-Related Disorders; Time Factors; Treatment Outcome | 2005 |
[Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C].
Topics: Adult; Aged; Anemia; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin; Thyroiditis; Treatment Outcome; Viral Load | 2006 |
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Viral Load | 2007 |
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Treatment Outcome | 2007 |
Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
Topics: Adult; Anemia; Antiviral Agents; Depression; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Viral Load | 2008 |
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
Topics: Antidepressive Agents, Second-Generation; Antiviral Agents; Canada; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Psychometrics; Recombinant Proteins; Ribavirin; Sample Size; Severity of Illness Index; Treatment Outcome | 2008 |
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
Topics: Adult; Antiviral Agents; Cohort Studies; Depression; Fatigue; Female; Gene Frequency; Genotype; Hepatitis C, Chronic; Humans; Interferon Type I; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Serotonin Plasma Membrane Transport Proteins | 2009 |
55 other study(ies) available for ribavirin and Depression
| Article | Year |
|---|---|
Depression Disorders in Patients with Chronic Hepatitis C.
Topics: Antiviral Agents; Bosnia and Herzegovina; Buprenorphine; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Methadone; Ribavirin | 2020 |
The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Topics: Adult; Antiviral Agents; Cross-Sectional Studies; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Immunologic Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Longitudinal Studies; Male; Middle Aged; ortho-Aminobenzoates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tryptophan | 2021 |
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
Topics: Antiviral Agents; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin | 2021 |
Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea.
Topics: Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Prevalence; Prospective Studies; Psychiatric Status Rating Scales; Republic of Korea; Ribavirin; Sustained Virologic Response | 2017 |
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin.
Topics: Adult; Affect; Aged; Antiviral Agents; Attention; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Memory, Episodic; Middle Aged; Prospective Studies; Ribavirin; Sustained Virologic Response; Treatment Outcome | 2017 |
Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation.
Topics: Adult; Antiviral Agents; Depression; Diagnostic and Statistical Manual of Mental Disorders; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Ribavirin; Time Factors; Withholding Treatment | 2018 |
Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study.
Topics: Actigraphy; Adult; Aged; Antiviral Agents; Depression; Exercise; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Pilot Projects; Ribavirin; Treatment Outcome; Tryptophan; Viral Load; Young Adult | 2018 |
Getting more out of meta-analyses: a new approach to meta-analysis in light of unexplained heterogeneity.
Topics: Antidepressive Agents; Data Interpretation, Statistical; Depression; Hepatitis C; Humans; Hypericum; Meta-Analysis as Topic; Models, Statistical; Plant Extracts; Ribavirin; Treatment Outcome | 2019 |
Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
Topics: Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Prospective Studies; Psychiatric Status Rating Scales; Ribavirin | 2019 |
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study.
Topics: Adult; Antiviral Agents; Anxiety; Cognition; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Polyethylene Glycols; Prospective Studies; Ribavirin | 2019 |
Perspectives of a self-selected sample of former patients on the long-term health outcomes of interferon-based hepatitis C treatments: an exploratory study.
Topics: Adult; Aftercare; Anorexia; Antiviral Agents; Attitude of Health Personnel; Chronic Disease; Cognition Disorders; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neurotoxicity Syndromes; New South Wales; Patient Education as Topic; Qualitative Research; Quality of Life; Recurrence; Ribavirin; Sarcoidosis; Self Report; Severity of Illness Index; Treatment Outcome; Victoria | 2013 |
Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Cohort Studies; Depression; Drug Therapy, Combination; Fatigue; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; INDEL Mutation; Interferon-alpha; Interleukin-6; Middle Aged; Point Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Prospective Studies; Recombinant Proteins; Ribavirin; Serotonin; Serotonin Plasma Membrane Transport Proteins; White People | 2013 |
The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.
Topics: Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome | 2012 |
Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Cytokines; Depression; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Inflammation Mediators; Interferons; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Ribavirin; RNA, Viral; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Viral Load | 2014 |
Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.
Topics: Antiviral Agents; Communication; Depression; Educational Status; Female; Hepatitis C, Chronic; Humans; Insurance, Health; Interferons; Interpersonal Relations; Male; Medication Adherence; Physician-Patient Relations; Polyethylene Glycols; Proportional Hazards Models; Prospective Studies; Ribavirin; Self Efficacy | 2015 |
Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Topics: Adult; Analysis of Variance; Antiviral Agents; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Depression; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Nitric Oxide Synthase; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Ribavirin; Risk Factors; Time Factors | 2014 |
Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.
Topics: Adult; Antiviral Agents; Depression; Disease Progression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Multivariate Analysis; Ribavirin; Schizophrenia | 2014 |
Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
Topics: Adult; Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Personality Inventory; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2014 |
Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment.
Topics: Adult; Affect; Antiviral Agents; Cognition; Depression; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Psychological Tests; Recombinant Proteins; Ribavirin; Viral Load | 2014 |
Self-reported need for psychotherapy predicts interferon-induced depression in hepatitis C: stratification for interferon-free treatment.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Psychotherapy; Recombinant Proteins; Ribavirin; Self Report; Surveys and Questionnaires; Young Adult | 2015 |
[Natural human IFNβ and ribavirin combination therapy].
Topics: Aged; Depression; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-beta; Ribavirin; Thrombocytopenia | 2015 |
Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
Topics: Adult; Aged; Antidepressive Agents; Antiviral Agents; Depression; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Ribavirin | 2015 |
Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
Topics: Adrenocorticotropic Hormone; Adult; Antiviral Agents; Area Under Curve; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Fatigue; Female; Glucocorticoids; Hepatitis C; Humans; Hydrocortisone; Inflammation; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Receptors, Tumor Necrosis Factor, Type II; Ribavirin; Tumor Necrosis Factor-alpha | 2016 |
Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.
Topics: Adult; Antiviral Agents; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Depression; Female; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Incidence; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; Ribavirin; Tacrolimus Binding Proteins; Treatment Outcome; White People | 2016 |
Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.
Topics: Adult; Antiviral Agents; Cohort Studies; Depression; Female; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Poland; Polyethylene Glycols; Polymorphism, Genetic; Prevalence; Recombinant Proteins; Ribavirin | 2016 |
"Look, I'm fit, I'm positive and I'll be all right, thank you very much": coping with hepatitis C treatment and unrealistic optimism.
Topics: Adaptation, Psychological; Adjustment Disorders; Adult; Antiviral Agents; Attitude of Health Personnel; Culture; Decision Making; Denial, Psychological; Depression; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interview, Psychological; Male; Middle Aged; New South Wales; Patient Acceptance of Health Care; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sick Role | 2008 |
Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.
Topics: Affect; Antiviral Agents; Biomarkers; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy.
Topics: Adult; Antiviral Agents; Cohort Studies; Cytokines; Depression; Female; Hepatitis C, Chronic; Humans; Interleukin-10; Interleukin-2; Interleukin-4; Interleukin-6; Male; Middle Aged; Quality of Life; Ribavirin; Tumor Necrosis Factor-alpha | 2009 |
Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Drug Users; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Odds Ratio; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Failure; Viral Load | 2009 |
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.
Topics: Antiviral Agents; Chi-Square Distribution; Cross-Sectional Studies; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Multicenter Studies as Topic; Prevalence; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; United States | 2009 |
Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Blood Platelets; Citalopram; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Young Adult | 2010 |
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Topics: Adult; Antiviral Agents; Chemokine CCL2; Chromatography, High Pressure Liquid; Cytokines; Depression; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis C; Humans; Interferon-alpha; Kynurenine; Longitudinal Studies; Male; Middle Aged; Quinolinic Acid; Receptors, Tumor Necrosis Factor, Type II; Ribavirin; Statistics as Topic; Tryptophan | 2010 |
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Buprenorphine; Citalopram; Depression; Directly Observed Therapy; Drug Administration Schedule; Female; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2010 |
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Case-Control Studies; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon alpha-2; Interferon-alpha; Italy; Kynurenine; Male; Middle Aged; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Serotonin; Time Factors; Treatment Outcome; Tryptophan | 2011 |
[Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Incidence; Interferon-alpha; Retrospective Studies; Ribavirin | 2011 |
Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
Topics: Adult; Alleles; Antiviral Agents; Brazil; Cross-Sectional Studies; Depression; Depressive Disorder; Female; Genetic Association Studies; Genotype; Hepatitis C; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Ribavirin | 2011 |
Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Ethanol; Female; France; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Medication Adherence; Middle Aged; Prospective Studies; Ribavirin; Socioeconomic Factors; Substance Abuse, Intravenous; Surveys and Questionnaires | 2012 |
Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients.
Topics: Aged; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Treatment Outcome | 2011 |
Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus.
Topics: Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Logistic Models; Male; Medical Records; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2011 |
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Topics: Adult; Alcohol Drinking; Antidepressive Agents; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medical Records; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Ribavirin; Risk Factors; Substance-Related Disorders | 2003 |
Assessment of depression in patients with chronic hepatitis: effect of interferon treatment.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Depression; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; Surveys and Questionnaires | 2002 |
Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.
Topics: Adult; Aged; Antiviral Agents; Cardiovascular Diseases; Depression; Female; Follow-Up Studies; France; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2004 |
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Ribavirin | 2004 |
Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Ribavirin; Selective Serotonin Reuptake Inhibitors | 2005 |
Interferon-induced depression: prevalence and management.
Topics: Adult; Aged; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Prevalence; Prognosis; Review Literature as Topic; Ribavirin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2005 |
[Neuropsychiatric disorders in HCV-infected people--own observations].
Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Poland; Psychiatric Status Rating Scales; Quality of Life; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors; Treatment Outcome | 2005 |
Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?
Topics: Adult; Antiviral Agents; Comorbidity; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous | 2006 |
Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report.
Topics: Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2005 |
Depression, anemia and health-related quality of life in chronic hepatitis C.
Topics: Adult; Aged; Anemia; Antiviral Agents; Depression; Female; Follow-Up Studies; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Quality of Life; Recombinant Proteins; Ribavirin; Risk Factors; Surveys and Questionnaires | 2006 |
Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells.
Topics: Antiviral Agents; Blotting, Western; Depression; Gene Expression Regulation; Hepatitis; Humans; Interferon-alpha; Jurkat Cells; Lamivudine; Leukocytes, Mononuclear; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Serotonin; Serotonin Plasma Membrane Transport Proteins; T-Lymphocytes; U937 Cells | 2006 |
Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.
Topics: Adolescent; Adult; Antiviral Agents; Blood Coagulation Disorders; Combined Modality Therapy; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2007 |
Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.
Topics: Adolescent; Adult; Antidepressive Agents; Antiviral Agents; Citalopram; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Pilot Projects; Quality of Life; Ribavirin; Secondary Prevention; Severity of Illness Index; Treatment Outcome | 2007 |
Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?
Topics: Adolescent; Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.
Topics: Adult; Antiviral Agents; Anxiety Disorders; Chi-Square Distribution; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Educational Status; Emigrants and Immigrants; Employment; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Treatment Outcome | 2008 |
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Basal Ganglia; Depression; Fatigue; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychiatric Status Rating Scales; Reaction Time; Regression Analysis; Ribavirin | 2008 |